SEC Form 4 · accession 0001127602-15-013191
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert D Shallish Jr.
Officer — EVP, Finance, CFO
Period of report
Mar 31, 2015
Accepted (ET)
Apr 1, 2015 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 31, 2015 | M | 1,200 | $0.00 | A | 55,076 | D | |
| Common Stock | Mar 31, 2015 | F | 433 | $50.49 | D | 54,643 | D | |
| Common Stock | Mar 31, 2015 | M | 2,400 | $0.00 | A | 57,043 | D | |
| Common Stock | Mar 31, 2015 | F | 866 | $50.49 | D | 56,177 | D | |
| Common Stock | Mar 31, 2015 | M | 3,600 | $0.00 | A | 59,777 | D | |
| Common Stock | Mar 31, 2015 | F | 1,299 | $50.49 | D | 58,478 | D | |
| Common Stock | Mar 31, 2015 | M | 5,600 | $0.00 | A | 64,078 | D | |
| Common Stock | Mar 31, 2015 | F | 2,020 | $50.49 | D | 62,058 | D | |
| Common Stock | Mar 31, 2015 | M | 4,550 | $0.00 | A | 66,608 | D | |
| Common Stock | Mar 31, 2015 | F | 1,642 | $50.49 | D | 64,966 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rsus (restricted Stock Units)F1 | $0.00 | Mar 31, 2015 | M | 1,200 | D | — | Jun 1, 2020 | Common Stock | 1,200 | 0 | D |
| Rsus (restricted Stock Units)F1 | $0.00 | Mar 31, 2015 | M | 2,400 | D | — | Jun 1, 2021 | Common Stock | 2,400 | 0 | D |
| Rsus (restricted Stock Units)F1 | $0.00 | Mar 31, 2015 | M | 3,600 | D | — | Jun 1, 2022 | Common Stock | 3,600 | 0 | D |
| Rsus (restricted Stock Units)F1 | $0.00 | Mar 31, 2015 | M | 5,600 | D | — | Jun 1, 2023 | Common Stock | 5,600 | 0 | D |
| Rsus (restricted Stock Units)F1 | $0.00 | Mar 31, 2015 | M | 4,550 | D | — | Jun 1, 2024 | Common Stock | 4,550 | 0 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.